Are we ready for routine precision medicine? Highlights from the Milan Summit on Precision Medicine, Milan, Italy, 8–9 February 2018

5 Mar 2018

Luca Mazzarella

On 8 and 9 February 2018, the IFOM-IEO campus in Milan hosted the Milan summit on Precision Medicine, which gathered clinical and translational research experts from academia, industry and regulatory bodies to discuss the state of the art of precision medicine in Europe. The meeting was pervaded by a generalised feeling of excitement for a field that is perceived to be technologically mature for the transition into clinical routine but still hampered by numerous obstacles of a methodological, ethical, regulatory and possibly cultural nature. Through lively discussions, the attendees tried to identify
realistic ways to implement a technology-rich precision approach to cancer patients.

2069-navigating-social-networks-in-cancer-care-a-phenomenological-exploration-of-patient-experiences

Research: Navigating social networks in cancer care: a phenomenological exploration of patient experiences

Yousef Roosta, Hero Khezri, Vahid Hoseinpour, Mohamad Jebraeily, Amirhossein Rayegani, Saeed Razavi-Dizaji

30 Jan 2026

https://doi.org/10.3332/ecancer.2026.2069

Abstract | Full Article | PDF

2070-locally-advanced-breast-cancer-is-the-number-of-dissected-nodes-after-neoadjuvant-chemotherapy-important

Review: Locally advanced breast cancer is the number of dissected nodes after neoadjuvant chemotherapy important?

Josepmilly Del Valle Peña Colmenares, Wladimir José Villegas Rodríguez, Osama Bahsas Zaky, Carlos Eduardo Martínez, Douglas José Angulo Herrera

30 Jan 2026

https://doi.org/10.3332/ecancer.2026.2070

Abstract | Full Article | PDF

2067-a-report-from-the-second-tanzania-liver-cancer-conference-tlcc-2025-leading-the-fight-against-liver-cancer-in-sub-saharan-africa

Conference Report: A report from the Second Tanzania Liver Cancer Conference (TLCC) 2025 – leading the fight against liver cancer in Sub-Saharan Africa

Ally H Mwanga, Jeanine Justiniano, Eric M Mbuguje, Balowa Musa, Deogratius B Mwanakulya, Andrew Swallow, Edith Kimambo, Eva Uiso, Swaleh Pazi, Latifa Rajab, Nashivai E Kivuyo, Larry Akoko, Azza Naif, Advera Ngaiza, Sara Nyagabona, Jerry Ndumbalo, Amos R Mwakigonja, Jim E Littlejohn, Seif Wibonela, Cameron E Gaskill

22 Jan 2026

https://doi.org/10.3332/ecancer.2026.2067

Abstract | Full Article | PDF

2059-oncology-with-common-sense-beyond-biologistic-and-pharmacological-models

Policy: Oncology with common sense: beyond biologistic and pharmacological models

Rodrigo Lastra, Patricia Iranzo, Javier-David Benítez-Fuentes, Ana Callejo, Mara Cruellas, Jacobo Gómez Ulla, Isabel Pimentel, José Luis Pérez-Gracia, Marta Ramos, Francisco Gil Moncayo, María Álvarez Alejandro, Marta Gascón, Sergio Martínez Recio, Pilar Rivero, Jorge Bartolomé, Antonio David Lázaro Sánchez, David Fernández Garay, Alicia de Luna Aguilar, Isabel Lorenzo Lorenzo, Joan Brunet, Noemi Reguart, Dario Trapani

16 Jan 2026

https://doi.org/10.3332/ecancer.2026.2059

Abstract | Full Article | PDF